Literature DB >> 8909541

A new model for the interaction of dystrophin with F-actin.

I N Rybakova1, K J Amann, J M Ervasti.   

Abstract

The F-actin binding and cross-linking properties of skeletal muscle dystrophin-glycoprotein complex were examined using high and low speed cosedimentation assays, microcapillary falling ball viscometry, and electron microscopy. Dystrophin-glycoprotein complex binding to F-actin saturated near 0.042 +/- 0.005 mol/ mol, which corresponds to one dystrophin per 24 actin monomers. Dystrophin-glycoprotein complex bound to F-actin with an average apparent Kd for dystrophin of 0.5 microM. These results demonstrate that native, full-length dystrophin in the glycoprotein complex binds F-actin with some properties similar to those measured for several members of the actin cross-linking super-family of proteins. However, we failed to observe dystrophin-glycoprotein complex-induced cross-linking of F-actin by three different methods, each positively controlled with alpha-actinin. Furthermore, high speed cosedimentation analysis of dystrophin-glycoprotein complex digested with calpain revealed a novel F-actin binding site located near the middle of the dystrophin rod domain. Recombinant dystrophin fragments corresponding to the novel actin binding site and the first 246 amino acids of dystrophin both bound F-actin but with significantly lower affinity and higher capacity than was observed with purified dystrophin-glycoprotein complex. Finally, dystrophin-glycoprotein complex was observed to significantly slow the depolymerization of F-actin, Suggesting that dystrophin may lie along side an actin filament through interaction with multiple actin monomers. These data suggest that although dystrophin is most closely related to the actin cross-linking superfamily based on sequence homology, dystrophin binds F-actin in a manner more analogous to actin side-binding proteins.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8909541      PMCID: PMC2121071          DOI: 10.1083/jcb.135.3.661

Source DB:  PubMed          Journal:  J Cell Biol        ISSN: 0021-9525            Impact factor:   10.539


  72 in total

1.  The N-terminal half of dystrophin is protected from proteolysis in situ.

Authors:  S Hori; S Ohtani; T M Nguyen; G E Morris
Journal:  Biochem Biophys Res Commun       Date:  1995-04-26       Impact factor: 3.575

Review 2.  Dystrophin and utrophin: the missing links!

Authors:  S J Winder; T J Gibson; J Kendrick-Jones
Journal:  FEBS Lett       Date:  1995-08-01       Impact factor: 4.124

3.  Dp71 can restore the dystrophin-associated glycoprotein complex in muscle but fails to prevent dystrophy.

Authors:  G A Cox; Y Sunada; K P Campbell; J S Chamberlain
Journal:  Nat Genet       Date:  1994-12       Impact factor: 38.330

4.  Exogenous Dp71 restores the levels of dystrophin associated proteins but does not alleviate muscle damage in mdx mice.

Authors:  D S Greenberg; Y Sunada; K P Campbell; D Yaffe; U Nudel
Journal:  Nat Genet       Date:  1994-12       Impact factor: 38.330

5.  Alternate binding of actin and calmodulin to multiple sites on dystrophin.

Authors:  H W Jarrett; J L Foster
Journal:  J Biol Chem       Date:  1995-03-10       Impact factor: 5.157

6.  Membrane organization of the dystrophin-glycoprotein complex.

Authors:  J M Ervasti; K P Campbell
Journal:  Cell       Date:  1991-09-20       Impact factor: 41.582

7.  A novel dystrophin isoform is required for normal retinal electrophysiology.

Authors:  V N D'Souza; T M Nguyen; G E Morris; W Karges; D A Pillers; P N Ray
Journal:  Hum Mol Genet       Date:  1995-05       Impact factor: 6.150

8.  Mechanisms responsible for F-actin stabilization after lysis of polymorphonuclear leukocytes.

Authors:  M L Cano; L Cassimeris; M Fechheimer; S H Zigmond
Journal:  J Cell Biol       Date:  1992-03       Impact factor: 10.539

9.  Inhibition of actin-dystrophin interaction by inositide phosphate.

Authors:  C Méjean; M C Lebart; C Roustan; Y Benyamin
Journal:  Biochem Biophys Res Commun       Date:  1995-05-05       Impact factor: 3.575

10.  SH3 domain-mediated interaction of dystroglycan and Grb2.

Authors:  B Yang; D Jung; D Motto; J Meyer; G Koretzky; K P Campbell
Journal:  J Biol Chem       Date:  1995-05-19       Impact factor: 5.157

View more
  67 in total

1.  Binding of dystrophin's tandem calponin homology domain to F-actin is modulated by actin's structure.

Authors:  A Orlova; I N Rybakova; E Prochniewicz; D D Thomas; J M Ervasti; E H Egelman
Journal:  Biophys J       Date:  2001-04       Impact factor: 4.033

Review 2.  Understanding dystrophinopathies: an inventory of the structural and functional consequences of the absence of dystrophin in muscles of the mdx mouse.

Authors:  J M Gillis
Journal:  J Muscle Res Cell Motil       Date:  1999-10       Impact factor: 2.698

Review 3.  Syntrophins entangled in cytoskeletal meshwork: Helping to hold it all together.

Authors:  Sahar S Bhat; Roshia Ali; Firdous A Khanday
Journal:  Cell Prolif       Date:  2018-12-04       Impact factor: 6.831

4.  Disease-causing missense mutations in actin binding domain 1 of dystrophin induce thermodynamic instability and protein aggregation.

Authors:  Davin M Henderson; Ann Lee; James M Ervasti
Journal:  Proc Natl Acad Sci U S A       Date:  2010-05-10       Impact factor: 11.205

5.  PC phosphorylation increases the ability of AFAP-110 to cross-link actin filaments.

Authors:  Yong Qian; Joseph M Baisden; Lidia Cherezova; Justin M Summy; Anne Guappone-Koay; Xianglin Shi; Tom Mast; Jennifer Pustula; Henry G Zot; Nayef Mazloum; Marietta Y Lee; Daniel C Flynn
Journal:  Mol Biol Cell       Date:  2002-07       Impact factor: 4.138

6.  Direct interaction of beta-dystroglycan with F-actin.

Authors:  Yun-Ju Chen; Heather J Spence; Jacqueline M Cameron; Thomas Jess; Jane L Ilsley; Steven J Winder
Journal:  Biochem J       Date:  2003-10-15       Impact factor: 3.857

7.  Impacts of dystrophin and utrophin domains on actin structural dynamics: implications for therapeutic design.

Authors:  Ava Yun Lin; Ewa Prochniewicz; Davin M Henderson; Bin Li; James M Ervasti; David D Thomas
Journal:  J Mol Biol       Date:  2012-04-11       Impact factor: 5.469

8.  Myosin binding protein C interaction with actin: characterization and mapping of the binding site.

Authors:  Inna N Rybakova; Marion L Greaser; Richard L Moss
Journal:  J Biol Chem       Date:  2010-11-11       Impact factor: 5.157

9.  Structural and functional analysis of the sarcoglycan-sarcospan subcomplex.

Authors:  Gaynor Miller; Emily L Wang; Karin L Nassar; Angela K Peter; Rachelle H Crosbie
Journal:  Exp Cell Res       Date:  2006-12-14       Impact factor: 3.905

Review 10.  Gene replacement therapies for duchenne muscular dystrophy using adeno-associated viral vectors.

Authors:  Jane T Seto; Julian N Ramos; Lindsey Muir; Jeffrey S Chamberlain; Guy L Odom
Journal:  Curr Gene Ther       Date:  2012-06       Impact factor: 4.391

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.